Here is the breakdown:
Monday @ 10:00am: Successful and Persistent Engraftment of ZFN-M-R5-D Autologous CD4 T Cells (SB-728-T) in Aviremic HIV-infected Subjects on HAART.
Monday @ 10:15am: Creating an HIV-resistant Immune System: Using CXCR4 ZFN to edit the Human Genome.
Wednesday between 4pm-6pm: CCR5 Knock-out in Hematopoietic Stem Cells
and
Wednesday between 4pm-6pm: Disruption of CCR5 in Zinc Finger Nuclease-treated CD4 T Cells: Phase I Trials


Thanks to David Sobek (@dsobek) for finding this and posting it on twitter and Mel Vogel (@MelVogelWP for retweeting it and breaking it on the StockTwits.com stream where it was brought to my attention.
Follow me on Twitter @Elwalvador
Disclaimer: In no way should anything that I say or type be taken as a recommendation to buy or sell any security. I am merely stating what I am doing with my money. What you do with your money is your responsibility. Trading stocks and options is extremely risky and you could lose all of your money.
No comments:
Post a Comment